id: oral_nifedipine_administration_to_postpartum_severe_hypertension_control
name: Oral Short-Acting Nifedipine Administration â†’ Postpartum Severe Hypertension
  Control
from_node:
  node_id: oral_nifedipine_administration
  node_name: Oral Short-Acting Nifedipine Administration
to_node:
  node_id: postpartum_severe_hypertension_control
  node_name: Postpartum Severe Hypertension Control
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Oral short-acting nifedipine provides accessible route of administration
  that does not require IV access or specialized equipment'
- 'Step 2: Calcium channel blocker mechanism relaxes vascular smooth muscle, reducing
  peripheral vascular resistance'
- 'Step 3: Blood pressure reduction occurs through vasodilation, bringing systolic
  BP below 160 mmHg and diastolic BP below 110 mmHg'
- 'Step 4: Ease of oral administration may facilitate faster medication delivery in
  resource-limited settings or busy postpartum units'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Whitney A Booker et al. 2025. "Short-Acting Oral Nifedipine versus
    Intravenous Labetalol for the Control of Severe Hypertension in the Postpartum
    Period: A Retrospective Cohort Study.." *American journal of perinatology*. https://doi.org/10.1055/a-2422-9768'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.474518'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: healthcare_facility_resources
  direction: strengthens
  strength: moderate
  description: Facilities with limited IV access capabilities or nursing resources
    may benefit more from oral medication routes
- name: time_to_medication_administration
  direction: strengthens
  strength: moderate
  description: Settings where IV access is delayed may see greater benefit from oral
    administration
